Aflac Incorporated $AFL Stock Holdings Lowered by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC decreased its position in Aflac Incorporated (NYSE:AFL) by 4.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 230,395 shares of the financial services provider’s stock after selling 10,879 shares during the period. Nisa Investment Advisors LLC’s holdings in Aflac were worth $24,297,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. AG2R LA Mondiale Gestion D Actifs bought a new position in Aflac in the 1st quarter worth approximately $2,070,000. Belpointe Asset Management LLC bought a new position in shares of Aflac in the first quarter worth $551,000. Golden State Wealth Management LLC grew its stake in shares of Aflac by 121.9% in the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 167 shares in the last quarter. Strs Ohio bought a new position in Aflac in the 1st quarter valued at about $2,626,000. Finally, Thurston Springer Miller Herd & Titak Inc. grew its position in Aflac by 11.8% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 32,982 shares of the financial services provider’s stock valued at $3,478,000 after buying an additional 3,484 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $102.57, for a total value of $102,570.00. Following the completion of the transaction, the director owned 25,105 shares of the company’s stock, valued at approximately $2,575,019.85. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.80% of the stock is currently owned by insiders.

Aflac Stock Performance

AFL opened at $107.22 on Monday. The firm has a market cap of $57.34 billion, a PE ratio of 24.31, a P/E/G ratio of 2.97 and a beta of 0.86. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33. The business has a fifty day simple moving average of $108.67 and a 200-day simple moving average of $105.60. Aflac Incorporated has a fifty-two week low of $96.95 and a fifty-two week high of $115.43.

Aflac (NYSE:AFL) last released its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%.The business had revenue of $5.91 billion during the quarter. As a group, equities analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac declared that its board has approved a share repurchase program on Tuesday, August 12th that permits the company to repurchase 100,000,000 shares. This repurchase authorization permits the financial services provider to reacquire shares of its stock through open market purchases. Shares repurchase programs are generally a sign that the company’s board believes its stock is undervalued.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Wednesday, August 20th were issued a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Wednesday, August 20th. Aflac’s dividend payout ratio (DPR) is presently 52.61%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AFL. Wall Street Zen upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. Morgan Stanley increased their price target on Aflac from $108.00 to $113.00 and gave the company an “equal weight” rating in a research note on Monday, August 18th. JPMorgan Chase & Co. increased their price target on Aflac from $96.00 to $100.00 and gave the company a “neutral” rating in a research note on Tuesday, July 8th. Piper Sandler set a $125.00 price target on Aflac and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Finally, UBS Group decreased their target price on Aflac from $114.00 to $111.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Three analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $109.45.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.